{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:15:21Z","timestamp":1791753321043,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1195,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Italian MS Society","award":["Ref.\u00a02010\/R\/24"],"award-info":[{"award-number":["Ref.\u00a02010\/R\/24"]}]},{"name":"UK MS society","award":["Ref.\u00a0938\/10"],"award-info":[{"award-number":["Ref.\u00a0938\/10"]}]},{"name":"UK MS Society and UK Stem Cell Foundation, and the Medical Research Council","award":["Ref.\u00a0G0800679"],"award-info":[{"award-number":["Ref.\u00a0G0800679"]}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.bbmt.2011.11.020","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T10:41:18Z","timestamp":1326105678000},"page":"S177-S183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S","title":["Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease\u2014Is It Now Ready for Prime\u00a0Time?"],"prefix":"10.1016","volume":"18","author":[{"given":"Harold L.","family":"Atkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo A.","family":"Muraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.bbmt.2011.11.020_bib1","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.bbmt.2009.10.034","article-title":"Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States","author":"Sullivan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.020_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2019 experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2011.11.020_bib3","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1182\/blood-2011-06-356576","article-title":"HSCT for AID: entering prime time?","volume":"118","author":"Pavletic","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.020_bib4","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","volume":"2","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bbmt.2011.11.020_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.wco.0000073930.19076.1b","article-title":"Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges","volume":"16","author":"Muraro","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.bbmt.2011.11.020_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2011.11.020_bib7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1474-4422(08)70138-8","article-title":"Autologous haematopoietic stem-cell transplantation in multiple sclerosis","volume":"7","author":"Mancardi","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bbmt.2011.11.020_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.57.1.62","article-title":"Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS","volume":"57","author":"Mancardi","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2011.11.020_bib9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1212\/WNL.56.8.1084","article-title":"MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS","volume":"56","author":"Saiz","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2011.11.020_bib10","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood-2004-08-3205","article-title":"Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life","volume":"105","author":"Saccardi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.020_bib11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1352458506071301","article-title":"Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database","volume":"12","author":"Saccardi","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.bbmt.2011.11.020_bib12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/1352458510364538","article-title":"High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience","volume":"16","author":"Krasulova","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.bbmt.2011.11.020_bib13","first-page":"405","article-title":"[Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis]","volume":"23","author":"Saiz","year":"2008","journal-title":"Neurologia"},{"key":"10.1016\/j.bbmt.2011.11.020_bib14","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood-2003-03-0877","article-title":"Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a\u00a0total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores","volume":"102","author":"Burt","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.020_bib15","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2002-12-3908","article-title":"High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis","volume":"102","author":"Nash","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.020_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","article-title":"Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I\/II study","volume":"8","author":"Burt","year":"2009","journal-title":"Lancet. Neurol"},{"key":"10.1016\/j.bbmt.2011.11.020_bib17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.exphem.2008.03.001","article-title":"High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis","volume":"36","author":"Shevchenko","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2011.11.020_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1352458508096875","article-title":"Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation","volume":"15","author":"Fagius","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.bbmt.2011.11.020_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/1352458507082604","article-title":"Autologous stem-cell transplantation in malignant multiple sclerosis:\u00a0a case with a favorable long-term outcome","volume":"14","author":"Kimiskidis","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.bbmt.2011.11.020_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/1352458506073502","article-title":"Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases","volume":"13","author":"Portaccio","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.bbmt.2011.11.020_bib21","unstructured":"Center for International Blood and Marrow Transplant Research Website (last accessed September 15, 2011). Available at: www.cibmtr.org\/DataManagement\/DataCollectionForms\/Documents\/2043\/Rev2.0\/combine-2043%20MS%20v2.pdf"},{"key":"10.1016\/j.bbmt.2011.11.020_bib22","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1212\/WNL.54.11.2147","article-title":"Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor","volume":"54","author":"Openshaw","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.bbmt.2011.11.020_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-60327-931-4_16","article-title":"Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosis","volume":"549","author":"Atkins","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bbmt.2011.11.020_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bmt.2009.127","article-title":"Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM\/horse ATG and CY\/rabbit ATG","volume":"45","author":"Hamerschlak","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.020_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1083-8791(03)00228-3","article-title":"Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases","volume":"9","author":"Nash","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.11.020_bib26","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2011-02-336156","article-title":"Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party","volume":"118","author":"Daikeler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.020_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.60.6.577","article-title":"Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease","volume":"60","author":"Binks","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bbmt.2011.11.020_bib28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","article-title":"High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study","volume":"110","author":"Nash","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.11.020_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/ard.2007.071464","article-title":"Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis","volume":"67","author":"Vonk","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bbmt.2011.11.020_bib30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111004988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111004988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:41:42Z","timestamp":1761057702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879111004988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1083879111004988"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.11.020","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease\u2014Is It Now Ready for Prime\u00a0Time?","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}